J&J, BMS arthritis drugs lowered death risk among COVID patients in federal study

The National Institutes of Health (NIH) led a large clinical trial on rheumatoid arthritis drugs in hospitalized COVID-19 patients. While researchers found that the treatments did not significantly shorten recovery time, they did improve clinical status and reduce deaths.